GKC – BioScience Managers

Data Published in Functional Neurology Demonstrate that Global Kinetics’ Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable Objective Assessment of Motor Fluctuations in Parkinson’s Disease Patients

23rd July 2019/in GKC

Link to Full Article Unlike patient-reported motor diaries, PKG distinguishes among different groups of fluctuators and identifies high levels of dyskinesia among patients who deny having dyskinesia symptoms PORTSMOUTH, NH USA, LONDON, UK and MELBOURNE, Australia, July 23, 2019 – Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use […]

Global Kinetics’ Personal KinetiGraph Identies Parkinson’s Patients Suitable For Deep Brain Stimulation

20th June 2019/in GKC

Link to Full Article Executive Summary A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep […]

Global Kinetics’ Personal KinetiGraph Identies Parkinson’s Patients Suitable For Deep Brain Stimulation

19th June 2019/in GKC

Link to Full Article A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep brain stimulation, […]

Data Published in Sensors Supports the Use of Global Kinetics’ Personal KinetiGraph® for Objective Assessment of Parkinson’s Disease Patients Who May Benefit From Device-Assisted Therapies

4th June 2019/in GKC

Link to Full Article Novel screening tool provides first objective assessment for managing referral for deviceassisted therapy (DAT), including deep brain stimulation (DBS) and infusion therapies, and has potential to improve management of Parkinson’s Disease PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, June 04, 2019 (GLOBE NEWSWIRE) — Global Kinetics Corporation Ltd. today announced the […]

Global Kinetics Corporation’s PKG® Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication Optimization, and PatientClinician Conversations in Parkinson’s Disease

7th May 2019/in GKC

Link to Full Article Data Recently Presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical Study Continues Enrollment at 10 Movement Disorder Clinics in the U.S. PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, May 07, 2019 (GLOBE NEWSWIRE) — Global Kinetics today reported data that was recently presented at poster presentation sessions […]

Pilot Project Tests Wrist Device That Monitors Symptoms at Home

18th April 2019/in GKC

Link to full article A pilot project in the United Kingdom is testing a wrist device that is worn like a watch, called Personal Kinetigraph (PKG), to help Parkinson’s patients and their specialist healthcare providers to monitor their condition at home. The PKG, developed by Global Kinetics, will be tested in the “Developing Home-based Parkinson’s Care” project, […]

Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors

2nd April 2019/in GKC

Link to full article PORTSMOUTH, NH USA, and MELBOURNE, Australia, April 2, 2019 Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first FDA-cleared and CE-marked wearable watch for the objective treatment and management of Parkinson’s disease, called the Personal KinetiGraph® (PKG®), today announced the appointment of Gregory […]

Data Published in the Journal of Parkinson’s Disease Demonstrate Real-World Clinical Benefit of Global Kinetics’ Personal KinetiGraph® in Optimizing Parkinson’s Disease Therapy

4th February 2019/in GKC

– Additional monitoring data helped clinicians optimize drug therapy in nearly onethird of study patients – PORTSMOUTH, NH USA, LONDON, UK, MELBOURNE, Australia, and MOUNTAIN VIEW, CA USA February 4, 2019 – Global Kinetics Corporation Ltd., in conjunction with the Parkinson’s Institute and Clinical Center, today announced the publication of a joint study in the […]

The PKG has been recommended by two separate panel experts for routine management of Parkinson’s

21st August 2018/in GKC

Company update: Global Kinetics Corporation hits significant clinical milestones on its trajectory to revolutionise the treatment of Parkinson’s disease Leading digital health company Global Kinetics’ ground-breaking PKGTM technology recommended by world leading Parkinson’s experts ahead of achieving a key milestone on the path to USA reimbursement PORTSMOUTH, NH USA, LONDON, UK, and MELBOURNE, Australia, August […]